Passive smoking, cytochrome P450 gene polymorphisms and dysmenorrhea

  • Lou Lei
  • Linan Ye
  • Hong Liu
  • Changzhong Chen
  • Zhian Fang
  • Lihua Wang
  • Yonghua Hu
  • Dafang Chen
GENETIC EPIDEMIOLOGY

Abstract

Purpose This study investigated whether the association between passive smoking exposure and dysmenorrhea is modified by two susceptibility genes, CYP1A1MspI and CYP1A1HincII. Methods This report includes 1,645 (1,124 no dysmenorrhea, 521 dysmenorrhea) non-smoking and non-drinking newly wedding female workers at Anqing, China between June 1997 and June 2000. Multiple logistic regression models were used to estimate the associations of passive smoking exposure and genetic susceptibility with dysmenorrhea, adjusting for maternal age, BMI, age of menarche, education, vibration exposure, shift work, noise exposure, pregnancy history, perceived stress and physical laboring stress. Results In the passive smoking group, women who have C/C6235 genotype (OR = 1.8, 95% CI = 1.0–3.3) in CYP1A1MspI and Ile/Ile462 genotype (OR = 2.9, 95% CI = 1.1–7.7) in CYP1A1HincII was associated with an increased risk of dysmenorrhea. When stratified by women genotype, the adjusted OR of dysmenorrheal was 1.6 (95% CI = 1.2–2.1) for passive smoking group with Ile/Ile462 genotype, and 1.5 (95% CI = 1.0–2.1) with C/C6235 genotype, compared to non-passive smoking group, respectively. The data further showed that there was a significant combined effect between passive smoking and the CYP1A1 Msp1C/C6235 (OR = 1.5, 95% CI = 1.0–2.1), and HincII Ile/Ile462 (OR = 1.6, 95% CI = 1.2–2.1), respectively. Conclusion CYP1A1 MspI and HincII genotypes modified the association between passive smoking and dysmenorrhea.

Keywords

Cytochrome P450 Dysmenorrhea Polymorphism Genetic Passive smoke 

References

  1. 1.
    Andersch B, Milsom I. An epidemiologic study of young women with dysmenorrhea. Am J Obstet Gynecol. 1982;144(6):655–60.PubMedGoogle Scholar
  2. 2.
    Klein JR, Litt IF. Epidemiology of adolescent dysmenorrhea. Pediatrics. 1981;68(5):661–4.PubMedGoogle Scholar
  3. 3.
    Ylikorkala O, Dawood MY. New concepts in dysmenorrhea. Am J Obstet Gynecol. 1978;130(7):833–47.PubMedGoogle Scholar
  4. 4.
    Dawood MY. Dysmenorrhea. J Reprod Med. 1985;30(3):154–67.PubMedGoogle Scholar
  5. 5.
    Friederich MA. Dysmenorrhea. Women Health. 1983;8(2–3):91–106. doi:10.1300/J013v08n02_05.PubMedGoogle Scholar
  6. 6.
    Harlow SD, Park M. A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women. Br J Obstet Gynaecol. 1996;103(11):1134–42.PubMedGoogle Scholar
  7. 7.
    Kennedy S. Primary dysmenorrhoea. Lancet. 1997;349(9059):1116. doi:10.1016/S0140-6736(05)63018-8.PubMedCrossRefGoogle Scholar
  8. 8.
    Hornsby PP, Wilcox AJ, Weinberg CR. Cigarette smoking and disturbance of menstrual function. Epidemiology. 1998;9(2):193–8. doi:10.1097/00001648-199803000-00016.PubMedCrossRefGoogle Scholar
  9. 9.
    Parazzini F, Tozzi L, Mezzopane R, Luchini L, Marchini M, Fedele L. Cigarette smoking, alcohol consumption, and risk of primary dysmenorrhea. Epidemiology. 1994;5(4):469–72. doi:10.1097/00001648-199407000-00016.PubMedCrossRefGoogle Scholar
  10. 10.
    Sundell G, Milsom I, Andersch B. Factors influencing the prevalence and severity of dysmenorrhoea in young women. Br J Obstet Gynaecol. 1990;97(7):588–94.PubMedGoogle Scholar
  11. 11.
    Sloss EM, Frerichs RR. Smoking and menstrual disorders. Int J Epidemiol. 1983;12(1):107–9. doi:10.1093/ije/12.1.107.PubMedCrossRefGoogle Scholar
  12. 12.
    Montero P, Bernis C, Fernandez V, Castro S. Influence of body mass index and slimming habits on menstrual pain and cycle irregularity. J Biosoc Sci. 1996;28(3):315–23.PubMedCrossRefGoogle Scholar
  13. 13.
    Cholst IN, Carlon AT. Oral contraceptives and dysmenorrhea. J Adolesc Health Care. 1987;8(1):121–8. doi:10.1016/0197-0070(87)90253-1.PubMedCrossRefGoogle Scholar
  14. 14.
    Brunnemann KD, Hoffmann D. Analytical studies on tobacco-specific N-nitrosamines in tobacco and tobacco smoke. Crit Rev Toxicol. 1991;21(4):235–40. doi:10.3109/10408449109017910.PubMedCrossRefGoogle Scholar
  15. 15.
    Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev. 2000;9(1):3–28.PubMedGoogle Scholar
  16. 16.
    Gaedigk A, Spielberg SP, Grant DM. Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions. Pharmacogenetics. 1994;4(3):142–53. doi:10.1097/00008571-199406000-00005.PubMedCrossRefGoogle Scholar
  17. 17.
    Khaw KT, Tazuke S, Barrett-Connor E. Cigarette smoking and levels of adrenal androgens in postmenopausal women. N Engl J Med. 1988;318(26):1705–9.PubMedGoogle Scholar
  18. 18.
    Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett. 1990;263(1):131–3.PubMedCrossRefGoogle Scholar
  19. 19.
    Medicine CAoP. Smoking in China: 1996 National Prevalence Survey of smoking pattern. Beijing: China Science and Technology Press; 1997.Google Scholar
  20. 20.
    Gross-Bellard M, Oudet P, Chambon P. Isolation of high-molecular-weight DNA from mammalian cells. Eur J Biochem. 1973;36(1):32–8. doi:10.1111/j.1432-1033.1973.tb02881.x.PubMedCrossRefGoogle Scholar
  21. 21.
    Katoh T, Inatomi H, Nagaoka A, Sugita A. Cytochrome P4501A1 gene polymorphism and homozygous deletion of the glutathione S-transferase M1 gene in urothelial cancer patients. Carcinogenesis. 1995;16(3):655–7. doi:10.1093/carcin/16.3.655.PubMedCrossRefGoogle Scholar
  22. 22.
    Treloar SA, Martin NG, Heath AC. Longitudinal genetic analysis of menstrual flow, pain, and limitation in a sample of Australian twins. Behav Genet. 1998;28(2):107–16. doi:10.1023/A:1021419907305.PubMedCrossRefGoogle Scholar
  23. 23.
    Wu D, Wang X, Chen D, Niu T, Ni J, Liu X, Xu X. Metabolic gene polymorphisms and risk of dysmenorrhea. Epidemiology. 2000;11(6):648–53. doi:10.1097/00001648-200011000-00006.PubMedCrossRefGoogle Scholar
  24. 24.
    Wu D, Chen D, Liu X, Ni J, Jin Y, Xu X. [Analysis on associations of cytochrome P450 1A1-Hinc II and glutathion S-transferase-theta with primary dysmenorrhea]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2001;18(1):47–50.PubMedGoogle Scholar
  25. 25.
    Windham GC, Hopkins B, Fenster L, Swan SH. Prenatal active or passive tobacco smoke exposure and the risk of preterm delivery or low birth weight. Epidemiology. 2000;11(4):427–33. doi:10.1097/00001648-200007000-00011.PubMedCrossRefGoogle Scholar
  26. 26.
    Landi MT, Bertazzi PA, Shields PG, Clark G, Lucier GW, Garte SJ, Cosma G, Caporaso NE. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics. 1994;4(5):242–6. doi:10.1097/00008571-199410000-00002.PubMedCrossRefGoogle Scholar
  27. 27.
    Crofts F, Taioli E, Trachman J, Cosma GN, Currie D, Toniolo P, Garte SJ. Functional significance of different human CYP1A1 genotypes. Carcinogenesis. 1994;15(12):2961–3. doi:10.1093/carcin/15.12.2961.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  • Lou Lei
    • 1
  • Linan Ye
    • 1
  • Hong Liu
    • 1
  • Changzhong Chen
    • 2
  • Zhian Fang
    • 3
  • Lihua Wang
    • 1
  • Yonghua Hu
    • 1
  • Dafang Chen
    • 1
  1. 1.Department of Epidemiology and Biostatistics, School of Public HealthPeking University Health Science CenterBeijingChina
  2. 2.Brigham and Women’s hospitalHarvard Medical SchoolBostonUSA
  3. 3.Anhui Biomedical InstituteAnhui ProvinceChina

Personalised recommendations